This research stack combines CJC-1295 without DAC (a GHRH analogue) and Ipamorelin (a selective GHRP) in a single vial at 5mg each. Both peptides have been independently studied for their roles in growth hormone secretagogue pathways, with research examining their combined receptor activity at GHRH and ghrelin receptors respectively.

CJC-1295 without DAC has a shorter active window than its DAC counterpart, while Ipamorelin is noted in research for its selectivity profile. Together they represent a commonly studied combination in GH axis research.

Each vial is supplied as lyophilized powder, third-party tested via LC-MS analysis, and ships with a Certificate of Analysis.

Specifications: CJC-1295 w/o DAC CAS: 863288-34-0 | Ipamorelin CAS: 170851-70-4 | Purity: >99% | Form: Lyophilized Powder | Storage: -20°C long-term / 4°C short-term

⚠️ For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.